Verastem names Daniel Paterson COO
This article was originally published in Scrip
Executive Summary
Verastem, a company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, has appointed Daniel Paterson, current chief business officer, to the role of chief operating officer. Mr Paterson has been at Verastem since 2012, initially joining the company as a consultant. Prior to working at Verastem, he was COO of On-Q-ity following its acquisition of The DNA Repair Company where he was the CEO and president from 2006.